All lobbying filings

LMH STRATEGIC SOLUTIONS

Lobbying for ARDELYX, INC. · Biopharmaceutical company.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $30,000.00 income · posted Apr 17, 2026

Official filing document

Lobbying activity 2

Health Issues

General health care coverage and reimbursement for prescription drugs.

Pharmacy

General health care coverage and reimbursement for prescription drugs. Drug pricing reform. Food and Drug Administration legislative and regulatory issues.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.